4.6 Article

Deep Belief Networks (DBN) with IoT-Based Alzheimer's Disease Detection and Classification

期刊

APPLIED SCIENCES-BASEL
卷 13, 期 13, 页码 -

出版社

MDPI
DOI: 10.3390/app13137833

关键词

Deep Belief Network; DBN; machine learning; healthcare; disease detection; alzheimer; IoT

向作者/读者索取更多资源

Dementias in older people, particularly Alzheimer's disease (AD), pose significant challenges to modern medicine. Machine learning techniques applied to MRI can accelerate the diagnosis of AD and predict its progression. This research explores the use of longitudinal brain MRI features and a Deep Belief Network trained with the Mayfly Optimization Algorithm for the AD/non-AD classification of dementia patients. Including information about comorbidities and medication characteristics greatly enhances the predictive power of the models, with the random forest model outperforming others in terms of precision.
Dementias that develop in older people test the limits of modern medicine. As far as dementia in older people goes, Alzheimer's disease (AD) is by far the most prevalent form. For over fifty years, medical and exclusion criteria were used to diagnose AD, with an accuracy of only 85 per cent. This did not allow for a correct diagnosis, which could be validated only through postmortem examination. Diagnosis of AD can be sped up, and the course of the disease can be predicted by applying machine learning (ML) techniques to Magnetic Resonance Imaging (MRI) techniques. Dementia in specific seniors could be predicted using data from AD screenings and ML classifiers. Classifier performance for AD subjects can be enhanced by including demographic information from the MRI and the patient's preexisting conditions. In this article, we have used the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. In addition, we proposed a framework for the AD/non-AD classification of dementia patients using longitudinal brain MRI features and Deep Belief Network (DBN) trained with the Mayfly Optimization Algorithm (MOA). An IoT-enabled portable MR imaging device is used to capture real-time patient MR images and identify anomalies in MRI scans to detect and classify AD. Our experiments validate that the predictive power of all models is greatly enhanced by including early information about comorbidities and medication characteristics. The random forest model outclasses other models in terms of precision. This research is the first to examine how AD forecasting can benefit from using multimodal time-series data. The ability to distinguish between healthy and diseased patients is demonstrated by the DBN-MOA accuracy of 97.456%, f-Score of 93.187 %, recall of 95.789 % and precision of 94.621% achieved by the proposed technique. The experimental results of this research demonstrate the efficacy, superiority, and applicability of the DBN-MOA algorithm developed for the purpose of AD diagnosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据